Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Mandatory QR coding...

    Mandatory QR coding for APIs soon: DTAB

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-04-19T11:21:32+05:30  |  Updated On 19 April 2019 11:21 AM IST
    Mandatory QR coding for APIs soon: DTAB

    New Delhi: Drugs Technical Advisory Board (DTAB), functional under the Central Drugs and Standard (CDSCO) has recommended “making it mandatory to have quick response code (QR) coding on labels of Active Pharmaceutical Ingredient (API), the most important constituent of any drug formulation for tracing the origin and movement of APIs from manufacturers to formulators through a system of networking.’’


    Incorporating a system of a QR coding for API will reportedly provide key benefits including better price control and more effective quality control. The move will help regulate the sale of fake medicines. Besides, it will also establish transparency and track drugs subject to Goods and Services Tax(GST) which otherwise is neglected.


    A QR code is a unique two-dimensional matrix bar-code which is attached to products to obtain information about them and track their origin.


    The proposal to this effect was deliberated in a recent meeting held by top drug advisory body, Drugs Technical Advisory Board (DTAB). The board noted that in the supply chain for APIs, the “security and integrity in proper storage condition” played a very significant role to enhance quality supply. API is the most important constituent of any drug formulation.


    Also Read: All medical devices sold in India to be CDSCO certified: What is Means


    The Board further added that in various fora, stakeholders had suggested incorporating a system of a QR code on packing of APIs for tracing the origin and movement of APIs from manufacturers to formulators through a system of networking.


    "DTAB after detailed deliberation recommended to include necessary provisions under the Drugs and Cosmetics Rules, 1945 for making it mandatory to have QR coding on labels of APIs for tracing the origin and movement of APIs from manufacturers to formulators through a system of networking," reads the DTAB recommendation.


    APIs are the active raw materials used in medicines to give them their therapeutic effect. Currently, India relies on other nations for 60%-80% of its API supplies.


    Medical Dialogues had earlier reported that the Ministry of Chemicals and Fertilizers had released orders to make bar code mandatory of procurement of drugs under public procurement, effective from April 1 2019.


    Also Read: Bar Code to be made mandatory for public procurement of drugs

    Active Pharmaceutical IngredientAPIsCDSCOCentral Drugs Standard Control Organisationdrug manufacturersDrugs and Cosmetics Rules1945Drugs Technical Advisory BoardDTABgovt of indiapharmapharma newspharma news indiaQR codeQR coding

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok